SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-19-122487
Filing Date
2019-04-26
Accepted
2019-04-26 16:35:55
Documents
3
Group Members
TAKEDA PHARMACEUTICALS INTERNATIONAL AGTAKEDA PHARMACEUTICALS U.S.A., INC.TAKEDA VENTURES, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G d736667dsc13g.htm SC 13G 82102
2 EX-99.1 d736667dex991.htm EX-99.1 1108
3 EX-99.2 d736667dex992.htm EX-99.2 10237
  Complete submission text file 0001193125-19-122487.txt   95091
Mailing Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
Business Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Subject) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90985 | Film No.: 19772220
SIC: 2834 Pharmaceutical Preparations